Surveillance for stage I nonseminoma testicular cancer: Outcomes and long-term follow-up in a population-based cohort

Journal of Clinical Oncology

Volumn 32, Issue 34, 2014, Pages 3817-3823

  Daugaard, Gedske ^a   Gundgaard, Maria Gry ^a   Mortensen, Mette Saksø ^a   Agerbæk, Mads ^b   Holm, Niels Vilstrup ^c   Rørth, Mikael ^a   Von Der Maase, Hans ^a   Christensen, Ib Jarle ^a   Lauritsen, Jakob ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DENMARK; DISEASE SPECIFIC SURVIVAL; EMBRYONAL CARCINOMA; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NON SEMINOMATOUS GERMINOMA; ORCHIECTOMY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RECURRENCE FREE SURVIVAL; RETE TESTIS; TESTIS CANCER; TUMOR INVASION; BLOOD; DISEASE FREE SURVIVAL; HEALTH SURVEY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; NEOPLASMS, GERM CELL AND EMBRYONAL; PATHOLOGY; PREDICTIVE VALUE; RETROSPECTIVE STUDY; RISK FACTOR; SECONDARY; TESTICULAR NEOPLASMS; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; DENMARK; DISEASE-FREE SURVIVAL; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; ORCHIECTOMY; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; TESTICULAR NEOPLASMS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84912112612     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.53.5831     Document Type: Article

References (21)

1. Pedersen CB: The Danish Civil Registration System. Scand J Public Health 39(7 suppl):22-25, 2011
2. Lynge E, Lynge J, Rebolj M: The Danish National Patient Register. Scan J Pub Health 39(7 suppl):30-33, 2011
3. Juel K, Helweg-Larsen K: The Danish registers of causes of death. Dan Med Bull 46(4):354-357, 1999
4. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Statist Assn 53:457-481, 1958
5. Little RJA, Rubin DB: Statistical Analysis with Missing Data (ed 2). New York, NY Wiley & Sons, 2002
6. Harrell FE, Jr, Lee KL, Mark DB: Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361-387, 1996
7. International Germ Cell Consensus Classification: A prognostic factor-based staging system for metastatic germ cell cancers-International Germ Cell Cancer Collaborative Group. J Clin Oncol 15: 594-603, 1997
8. Kollmannsberger C, Moore C, Chi KN, et al: Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: Diminishing treatment-related morbidity while maintaining efficacy. Ann Oncol 6:1296-1301, 2010
9. Sturgeon JF, Moore MJ, Kakiashvili DM, et al: Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: The Princess Margaret Hospital's experience. Eur Urol 59:556-562, 2011
10. Stephenson AJ, Bosl GJ, Motzer RJ, et al: Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: Impact of patient selection factors on outcome. J Clin Oncol 23:2781-2788, 2005
11. Albers P, Siener R, Krege S, et al: Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group. J Clin Oncol 26:2966-2972, 2008
12. Tandstad T, Dahl O, Cohn-Cedermark G, et al: Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: The SWENOTECA management program. J Clin Oncol 27:2122-2128, 2009
13. Hotte SJ, Mayhew LA, Jewett M, et al: Management of stage I non-seminomatous testicular cancer: A systematic review and meta-analysis. Clin Oncol (R Coll Radiol) 22:17-26, 2010
14. Yilmaz A, Cheng T, Zhang J, et al: Testicular hilum and vascular invasion predict advanced clinical stage in nonseminomatous germ cell tumors. Mod Pathol 26:579-586, 2013
15. Freedman LS, Parkinson MC, Jones WG, et al: Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet 2:294-298, 1987
16. Read G, Stenning SP, Cullen MH, et al: Medical Research Council prospective study of surveillance for stage I testicular teratoma: Medical Research Council Testicular Tumors Working Party. J Clin Oncol 10:1762-1768, 1992
17. Vergouwe Y, Steyerberg E, Eijkemans M, et al: Predictors of occult metastasis in clinical stage I nonseminoma: A systematic review. J Clin Oncol 21:4092-4099, 2003
18. Pandharipande PV, Eisenberg JD, Lee RJ, et al: Patients with testicular cancer undergoing CT surveillance demonstrate a pitfall of radiationinduced cancer risk estimates: The timing paradox. Radiology 266:896-904, 2013
19. O'Malley ME, Chung P, Haider M, et al: Comparison of low dose with standard dose abdominal/ pelvic multidetector CT in patients with stage 1 testicular cancer under surveillance. Eur Radiol 20: 1624-1630, 2010
20. Rustin GJ, Mead GM, Stenning SP, et al: Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197 - the National Cancer Res Institute Testis Cancer Clinical Studies Group. J Clin Oncol 25:1310-1315, 2007
21. Baniel J, Foster RS, Einhorn LH, et al: Late relapse of clinical stage I testicular cancer. J Urol 154:1370-1372, 1995